600351 Stock Overview
Researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Yabao Pharmaceutical Group Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.82 |
| 52 Week High | CN¥9.00 |
| 52 Week Low | CN¥4.94 |
| Beta | 0.21 |
| 11 Month Change | 1.22% |
| 3 Month Change | -12.87% |
| 1 Year Change | -22.19% |
| 33 Year Change | -6.43% |
| 5 Year Change | 0.52% |
| Change since IPO | 45.97% |
Recent News & Updates
Shareholder Returns
| 600351 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 1.0% | 2.3% | -0.2% |
| 1Y | -22.2% | -11.1% | -19.8% |
Return vs Industry: 600351 underperformed the CN Pharmaceuticals industry which returned -11.1% over the past year.
Return vs Market: 600351 underperformed the CN Market which returned -19.8% over the past year.
Price Volatility
| 600351 volatility | |
|---|---|
| 600351 Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 600351 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600351's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 4,142 | Ren Wei | www.yabao.com.cn |
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. The company provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.
Yabao Pharmaceutical Group Co., Ltd Fundamentals Summary
| 600351 fundamental statistics | |
|---|---|
| Market cap | CN¥4.19b |
| Earnings (TTM) | CN¥204.43m |
| Revenue (TTM) | CN¥2.88b |
20.5x
P/E Ratio1.5x
P/S RatioIs 600351 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600351 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.88b |
| Cost of Revenue | CN¥1.25b |
| Gross Profit | CN¥1.63b |
| Other Expenses | CN¥1.42b |
| Earnings | CN¥204.43m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 15, 2024
| Earnings per share (EPS) | 0.28 |
| Gross Margin | 56.57% |
| Net Profit Margin | 7.10% |
| Debt/Equity Ratio | 7.0% |
How did 600351 perform over the long term?
See historical performance and comparison